Biomarkers of splenic function in infants with sickle cell anemia: Baseline data from the BABYHUG trial

Zora R. Rogers, Winfred C. Wang, Zhaoyu Luo, Rathi V. Iyer, Eglal Shalaby-Rana, Stephen D. Dertinger, Barry L. Shulkin, John H. Miller, Bea Files, Peter A. Lane, Bruce W. Thompson, Scott T. Miller, Russell E. Ware

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

We evaluated spleen function in 193 children with sickle cell anemia 8 to 18 months of age by 99mTc sulfur-colloid liver-spleen scan and correlated results with clinical and laboratory parameters, including 2 splenic biomarkers: pitted cell counts (PIT) and quantitative Howell-Jolly bodies (HJB) enumerated by flow cytometry. Loss of splenic function began before 12 months of age in 86% of infants in association with lower total or fetal hemoglobin and higher white blood cell or reticulocyte counts, reinforcing the need for early diagnosis and diligent preventive care. PIT and HJB correlated well with each other and liver-spleen scan results. Previously described biomarker threshold values did define patients with abnormal splenic function, but our data suggest that normal spleen function is better predicted by PIT of ≤ 1.2% or HJB ≤ 55/106 red blood cells and absent function by PIT ≥ 4.5% or HJB ≥ 665/106. HJB is methodologically advantageous compared with PIT, but both are valid biomarkers of splenic function. This trial was registered at www.clinicaltrials.gov as #NCT00006400.

Original languageEnglish (US)
Pages (from-to)2614-2617
Number of pages4
JournalBlood
Volume117
Issue number9
DOIs
StatePublished - Mar 3 2011

Fingerprint

Erythrocyte Inclusions
Sickle Cell Anemia
Biomarkers
Spleen
Liver
Blood
Reticulocyte Count
Fetal Hemoglobin
Cells
Preventive Medicine
Colloids
Leukocyte Count
Sulfur
Flow cytometry
Early Diagnosis
Flow Cytometry
Cell Count
Erythrocytes
Association reactions

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Rogers, Z. R., Wang, W. C., Luo, Z., Iyer, R. V., Shalaby-Rana, E., Dertinger, S. D., ... Ware, R. E. (2011). Biomarkers of splenic function in infants with sickle cell anemia: Baseline data from the BABYHUG trial. Blood, 117(9), 2614-2617. https://doi.org/10.1182/blood-2010-04-278747

Biomarkers of splenic function in infants with sickle cell anemia : Baseline data from the BABYHUG trial. / Rogers, Zora R.; Wang, Winfred C.; Luo, Zhaoyu; Iyer, Rathi V.; Shalaby-Rana, Eglal; Dertinger, Stephen D.; Shulkin, Barry L.; Miller, John H.; Files, Bea; Lane, Peter A.; Thompson, Bruce W.; Miller, Scott T.; Ware, Russell E.

In: Blood, Vol. 117, No. 9, 03.03.2011, p. 2614-2617.

Research output: Contribution to journalArticle

Rogers, ZR, Wang, WC, Luo, Z, Iyer, RV, Shalaby-Rana, E, Dertinger, SD, Shulkin, BL, Miller, JH, Files, B, Lane, PA, Thompson, BW, Miller, ST & Ware, RE 2011, 'Biomarkers of splenic function in infants with sickle cell anemia: Baseline data from the BABYHUG trial', Blood, vol. 117, no. 9, pp. 2614-2617. https://doi.org/10.1182/blood-2010-04-278747
Rogers, Zora R. ; Wang, Winfred C. ; Luo, Zhaoyu ; Iyer, Rathi V. ; Shalaby-Rana, Eglal ; Dertinger, Stephen D. ; Shulkin, Barry L. ; Miller, John H. ; Files, Bea ; Lane, Peter A. ; Thompson, Bruce W. ; Miller, Scott T. ; Ware, Russell E. / Biomarkers of splenic function in infants with sickle cell anemia : Baseline data from the BABYHUG trial. In: Blood. 2011 ; Vol. 117, No. 9. pp. 2614-2617.
@article{a47a7764bbc441959472cf06979d05aa,
title = "Biomarkers of splenic function in infants with sickle cell anemia: Baseline data from the BABYHUG trial",
abstract = "We evaluated spleen function in 193 children with sickle cell anemia 8 to 18 months of age by 99mTc sulfur-colloid liver-spleen scan and correlated results with clinical and laboratory parameters, including 2 splenic biomarkers: pitted cell counts (PIT) and quantitative Howell-Jolly bodies (HJB) enumerated by flow cytometry. Loss of splenic function began before 12 months of age in 86{\%} of infants in association with lower total or fetal hemoglobin and higher white blood cell or reticulocyte counts, reinforcing the need for early diagnosis and diligent preventive care. PIT and HJB correlated well with each other and liver-spleen scan results. Previously described biomarker threshold values did define patients with abnormal splenic function, but our data suggest that normal spleen function is better predicted by PIT of ≤ 1.2{\%} or HJB ≤ 55/106 red blood cells and absent function by PIT ≥ 4.5{\%} or HJB ≥ 665/106. HJB is methodologically advantageous compared with PIT, but both are valid biomarkers of splenic function. This trial was registered at www.clinicaltrials.gov as #NCT00006400.",
author = "Rogers, {Zora R.} and Wang, {Winfred C.} and Zhaoyu Luo and Iyer, {Rathi V.} and Eglal Shalaby-Rana and Dertinger, {Stephen D.} and Shulkin, {Barry L.} and Miller, {John H.} and Bea Files and Lane, {Peter A.} and Thompson, {Bruce W.} and Miller, {Scott T.} and Ware, {Russell E.}",
year = "2011",
month = "3",
day = "3",
doi = "10.1182/blood-2010-04-278747",
language = "English (US)",
volume = "117",
pages = "2614--2617",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

TY - JOUR

T1 - Biomarkers of splenic function in infants with sickle cell anemia

T2 - Baseline data from the BABYHUG trial

AU - Rogers, Zora R.

AU - Wang, Winfred C.

AU - Luo, Zhaoyu

AU - Iyer, Rathi V.

AU - Shalaby-Rana, Eglal

AU - Dertinger, Stephen D.

AU - Shulkin, Barry L.

AU - Miller, John H.

AU - Files, Bea

AU - Lane, Peter A.

AU - Thompson, Bruce W.

AU - Miller, Scott T.

AU - Ware, Russell E.

PY - 2011/3/3

Y1 - 2011/3/3

N2 - We evaluated spleen function in 193 children with sickle cell anemia 8 to 18 months of age by 99mTc sulfur-colloid liver-spleen scan and correlated results with clinical and laboratory parameters, including 2 splenic biomarkers: pitted cell counts (PIT) and quantitative Howell-Jolly bodies (HJB) enumerated by flow cytometry. Loss of splenic function began before 12 months of age in 86% of infants in association with lower total or fetal hemoglobin and higher white blood cell or reticulocyte counts, reinforcing the need for early diagnosis and diligent preventive care. PIT and HJB correlated well with each other and liver-spleen scan results. Previously described biomarker threshold values did define patients with abnormal splenic function, but our data suggest that normal spleen function is better predicted by PIT of ≤ 1.2% or HJB ≤ 55/106 red blood cells and absent function by PIT ≥ 4.5% or HJB ≥ 665/106. HJB is methodologically advantageous compared with PIT, but both are valid biomarkers of splenic function. This trial was registered at www.clinicaltrials.gov as #NCT00006400.

AB - We evaluated spleen function in 193 children with sickle cell anemia 8 to 18 months of age by 99mTc sulfur-colloid liver-spleen scan and correlated results with clinical and laboratory parameters, including 2 splenic biomarkers: pitted cell counts (PIT) and quantitative Howell-Jolly bodies (HJB) enumerated by flow cytometry. Loss of splenic function began before 12 months of age in 86% of infants in association with lower total or fetal hemoglobin and higher white blood cell or reticulocyte counts, reinforcing the need for early diagnosis and diligent preventive care. PIT and HJB correlated well with each other and liver-spleen scan results. Previously described biomarker threshold values did define patients with abnormal splenic function, but our data suggest that normal spleen function is better predicted by PIT of ≤ 1.2% or HJB ≤ 55/106 red blood cells and absent function by PIT ≥ 4.5% or HJB ≥ 665/106. HJB is methodologically advantageous compared with PIT, but both are valid biomarkers of splenic function. This trial was registered at www.clinicaltrials.gov as #NCT00006400.

UR - http://www.scopus.com/inward/record.url?scp=79953089715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953089715&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-04-278747

DO - 10.1182/blood-2010-04-278747

M3 - Article

C2 - 21217080

AN - SCOPUS:79953089715

VL - 117

SP - 2614

EP - 2617

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -